GlassScriptPhysician profile
Bradley Whitaker
NPI 1821089624
$9,873.56
in general payments reported to CMS, 2019-2025
41 companies · $2,217 in 2025
The $2,217 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $76.34 · 2021: $197 · 2022: $235 · 2023: $827 · 2024: $6,080 · 2025: $2,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4,370 · Consulting Fee: $2,200 · Food and Beverage: $1,555 · Travel and Lodging: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,369.86 |
| Consulting Fee | $2,200.00 |
| Food and Beverage | $1,554.67 |
| Travel and Lodging | $998.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $7,020.08 | 2024-2025 | Lapilock |
| Fusion Orthopedics, LLC. | $548.74 | 2023-2024 | Lapilock |
| Koya Medical, INC. | $273.51 | 2024 | Dayspring, Koya Medical |
| Nevro Corp. | $199.78 | 2023-2024 | Senza |
| Averitas Pharma INC. | $189.87 | 2023-2025 | Qutenza |
| Orthofix Medical, INC. | $178.97 | 2019-2022 | |
| Horizon Therapeutics Plc | $131.92 | 2020-2023 | Krystexxa |
| Smith+Nephew, INC. | $128.56 | 2021-2025 | Collagenase Santyl, Integraallograft Wedge System, Hallu Lock |
| Organogenesis INC. | $97.33 | 2021-2025 | Puraply, Cygnus Dual |
| Mimedx Group, INC. | $94.26 | 2024-2025 | |
| Treace Medical Concepts, INC. | $68.11 | 2023-2024 | |
| Tactile Systems Technology INC | $65.81 | 2019-2020 | |
| Stryker Corporation | $59.55 | 2025 | Augment Injectable |
| Medtronic, INC. | $59.22 | 2022-2023 | Intellis Adaptivestim |
| Abbvie INC. | $56.77 | 2021-2024 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $51.04 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $49.70 | 2023 | Seglentis |
| Biowound Solutions, INC. | $48.99 | 2025 | Bio-Connekt |
| Abbott Laboratories | $42.86 | 2023-2025 | Proclaim, Eterna |
| Melinta Therapeutics, LLC | $39.80 | 2019 | |
| Paratek Pharmaceuticals, INC. | $39.08 | 2023-2024 | Nuzyra |
| Advanced Oxygen Therapy INC. | $38.35 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Depuy Synthes Sales INC. | $36.52 | 2019 | |
| Amgen INC. | $33.96 | 2024-2025 | Krystexxa |
| Grt US Holding, INC. | $32.51 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $32.46 | 2022 | |
| Sobi, INC | $26.00 | 2025 | |
| Biotissue Holdings INC. | $25.47 | 2021-2022 | |
| Bioventus LLC | $23.72 | 2025 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $22.56 | 2023 | Exparel, Iovera |
| Djo, LLC | $18.89 | 2022 | |
| International Rehabilitative Sciences, INC | $16.81 | 2024 | Rs 4i Plus Sequential Stimulator |
| Solventum Corporation | $16.12 | 2024 | Prevena, V.A.C. Dermatac, V.A.C.Ulta |
| Integra Lifesciences Corporation | $16.06 | 2019 | |
| Osiris Therapeutics INC. | $14.47 | 2019 | |
| Medela LLC | $13.28 | 2021 | |
| Assertio Therapeutics, INC. | $13.17 | 2019 | |
| Orpyx Medical Technologies US INC. | $13.00 | 2023 | Orpyx Si |
| Merck Sharp & Dohme LLC | $12.67 | 2019 | |
| Alafair Biosciences, INC. | $11.82 | 2024 | Versawrap |
| Trice Medical, INC. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.